Evidence map›Paper›PMID 24914671›Full record

ArticlePloS one2014

High seroprevalence of human herpesviruses in HIV-infected individuals attending primary healthcare facilities in rural South Africa.

Erik Schaftenaar, Georges M G M Verjans, Sarah Getu, James A McIntyre, Helen E Struthers, Albert D M E Osterhaus, Remco P H Peters

Registry-linked trialOpen access · goldAbstract read
In one paragraph

Article in PloS one, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT03092505 (Herpesviruses Reactivation In Hiv-Infected Women Initiating ART), which is not on this map. Cited by 25 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
25citing papers in PubMed, 1 pooled it
4.3field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT03092505 completednot on this mapstarted 2018, after this paper: background citation

Herpesviruses Reactivation In Hiv-Infected Women Initiating ART (HERA)

TypeobservationalSponsorNational Institute of Allergy and Infectious Diseases (NIAID)Ran2018 to 2021Enrolled190ConditionsHerpes Virus-Related Illnesses
3 · Its place in the literature

Who cites it

25 citing papers in PubMed, 1 synthesis or guideline pooled it, 44 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Fulminant Yersinia Pestis Infection in a Known HIV-Positive Patient: A Case Report of Identification in Nigeria 2024.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America · 2025
    Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Multisystem cytomegalovirus end-organ disease in a patient with advanced HIV.Southern African journal of infectious diseases · 2022
    Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Clinical and corneal microbial profile of infectious keratitis in a high HIV prevalence setting in rural South Africa.European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology · 2016
    Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 2 countries.

Erik SchaftenaarDepartment of Viroscience, Erasmus Medical Center, Rotterdam, The Netherlands; Anova Health Institute, Johannesburg and Tzaneen, South Africa.
Georges M G M VerjansDepartment of Viroscience, Erasmus Medical Center, Rotterdam, The Netherlands.
Sarah GetuDepartment of Viroscience, Erasmus Medical Center, Rotterdam, The Netherlands.
James A McIntyreAnova Health Institute, Johannesburg and Tzaneen, South Africa; School of Public Health & Family Medicine, University of Cape Town, Cape Town, South Africa.
Helen E StruthersAnova Health Institute, Johannesburg and Tzaneen, South Africa; Department of Medicine, Division of Infectious Diseases & HIV Medicine, University of Cape Town, Cape Town, South Africa.
Albert D M E OsterhausDepartment of Viroscience, Erasmus Medical Center, Rotterdam, The Netherlands.
Remco P H PetersAnova Health Institute, Johannesburg and Tzaneen, South Africa; Department of Medical Microbiology, Maastricht University Medical Centre, Maastricht, The Netherlands.
Erasmus MC · NLAnova Health Institute · ZA

Funding

PEPFAR 674-A-00-08-00009-00
6 · The paper itself

Abstract

Seroprevalence data of human herpesviruses (HHVs) are limited for sub-Saharan Africa. These are important to provide an indication of potential burden of HHV-related disease, in particular in human immunodeficiency virus (HIV)-infected individuals who are known to be at increased risk of these conditions in the Western world. In this cross-sectional study among 405 HIV-infected and antiretroviral therapy naïve individuals in rural South Africa the seroprevalence of HHVs was: herpes simplex virus type 1 (HSV-1) (98%), herpes simplex virus type 2 (HSV-2) (87%), varicella zoster virus (VZV) (89%), and 100% for both Epstein-Barr virus (EBV) and cytomegalovirus (CMV). Independent factors associated with VZV seropositivity were low educational status and having children. Lack of in-house access to drinking water was independently associated with positive HSV-1 serostatus, whereas Shangaan ethnicity was associated with HSV-2 seropositivity. Increasing age was associated with higher IgG titres to both EBV and CMV, whereas CD4 cell count was negatively associated with EBV and CMV IgG titres. Moreover, IgG titres of HSV-1 and 2, VZV and CMV, and CMV and EBV were positively correlated. The high HHV seroprevalence emphasises the importance of awareness of these viral infections in HIV-infected individuals in South Africa.

Indexed as

AdultDemographyFemaleHIV InfectionsHumansImmunoglobulin GMalePrimary Health CareRisk FactorsRural PopulationSeroepidemiologic StudiesSimplexvirusSouth AfricaImmunoglobulin G

Identifiers

PMID24914671
PMCPMC4051661
OpenAlexW2135096092

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.